Chad Morin

Compliance Officer at

Kiniksa Pharmaceuticals Ltd.

Health Technology

Consumer Services

Profile

Chad Morin is currently Chief Compliance Officer & Vice President at Kiniksa Pharmaceuticals Ltd. since 2020.
Former positions include Head-Compliance at ARIAD Pharmaceuticals, Inc., Chief Compliance Officer & Senior Vice President at Kiniksa Pharmaceuticals International Plc from 2020 to 2025, and Chief Compliance Officer & Vice President at Genetix Biotherapeutics, Inc. Education includes undergraduate studies at F.W.
Olin Graduate School of Business.

Chad Morin active positions

Companies	Position	Start
Kiniksa Pharmaceuticals Ltd. Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases	Compliance Officer	30/09/2020

All active positions of Chad Morin

Former positions of Chad Morin

Companies	Position	End
ARIAD PHARMACEUTICALS, INC.	Compliance Officer	-
GENETIX BIOTHERAPEUTICS, INC.	Compliance Officer	-

See the detail of Chad Morin's experience

Training of Chad Morin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Chad Morin's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
ARIAD Pharmaceuticals, Inc. ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer	Health Technology
bluebird bio, Inc. bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells	Health Technology
F.W. Olin Graduate School of Business F.W. Olin Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Kiniksa Pharmaceuticals Ltd. Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases	Health Technology

See company connections